Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is -22.84% vs -20.77% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 29.15% vs -41.15% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -485.71% vs -96.93% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 10.05% vs -13.30% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of ANG Lifesciences With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 31.37% vs -34.89% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -22.84% vs -20.77% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 50.71% vs -207.25% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 29.15% vs -41.15% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 86.15% vs -173.03% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -485.71% vs -96.93% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -7.14% vs 2.75% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 10.05% vs -13.30% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025